Introduction
The globalization of technology markets has rendered a single jurisdiction patent protection commercially inadequate for most innovative enterprises. “A product launch across India, the United States, Europe, and Asian markets demand a patent portfolio strategically to align with business objectives, distribution networks, and manufacturing footprint. However, obtaining effective international patent protection is the complex process. Differences in examination standards, filing timelines, translation requirements, and jurisdiction specific procedures make it difficult to balance the adequate protection with costs. Enterprises also face the challenge of avoiding unnecessary filings in low-volume markets while ensuring sufficient protection in commercially important jurisdictions.
For technology driven enterprises, a well-constructed patent portfolio serves not merely as a legal shield but as a pivotal business asset that enhances valuation, attracts investments and enables licensing revenue.
India recorded 1,43,739 patent applications in FY 2025-2026, marking a 31.2 percent increase over the previous fiscal year. Globally, China filed 1.9 million patent applications in 2024, representing 49.01 percent of the world total. In this environment of intensifying patent activity, the ability to build up the strategic global portfolio has become a defining competitive advantage.
This blog provides a comprehensive roadmap for the founders, product teams, and the legal practitioners navigating multi-jurisdictional patent filings. It examines the legal frameworks in India, the United States, Europe, and a Key Asian jurisdiction, analyses portfolio layers, and offers practical guidance on or over the timing filings. The blog addresses Freedom to Operate analyses, claim drafting strategies, portfolio lifecycle management, and concludes with a framework for avoiding over-filing and under the protection.
Legal Provisions
A. The Indian Patents Act, 1970 and Foreign Filing Requirements
The Patents Act, 1970 constitutes the foundational statutory framework for the patent protection in India. Section 2(1)(j)[1] defines a patentable invention as one that is novel, involves an inventive step, and is capable of industrial application. Section governs the filing of patent applications, while Section 91) permits filing a provisional specification, providing an early priority date and granting twelve months to file the complete specifications. The complete specification under Section 10(4) must contain full disclosure and claims the defining legal scope of protection. Section 135 permits convention applications, allowing applicants who have filed in a convention country to claim priority in India within twelve months.
Section 11B provides that a patent application shall not be examined until the applicants files a request for examination. And as per Rule 24C of the Patents Rules, 2003[2], expedited examination is available for applicants who files in India first, startups, and small entities. Form 18A is filed for that purpose.
Critically, for Indian residents seeking an international protection, section 39 imposes a mandatory requirement to obtain a Foreign License (FFL) before filing patents abroad. The FFL, obtainable on Form 25, allows an Indian inventor to file internationally without first filing in India.
B. The Patent Cooperation Treaty (PCT) Framework
The Patent Cooperation Treaty, administered by WIPO, provides a unified procedural framework for seeking patent protection in over 158 contracting states. Under the PCT, an applicant’s files a single international application, preserving the priority date for up to 31 months, before entering the national phase. The Indian Patent office functions as the Receiving office, international Searching Authority, and International Preliminary Examining Authority.
The PCT system offers strategic advantages; additional time to decide which jurisdictions to pursue, international search reports providing valuable patentability insights, and a unified filing procedure reducing the administrative burden.
C. International Treaty Obligations
India is a signatory the TRIPS Agreements, 1994, establishing minimum intellectual property standards among WTO members. TRIPS Requires member states to protect patents for a minimum term of twenty years. The Paris convention, 1883, to which India is also a signatory, establish the right of priority, allowing applicants to claim the filing date of an earlier application in one member state when filing in another within twelve months.[3]
Legal Analysis
A. Portfolio Layers: Core Inventions, Improvements, and Jurisdictional Coverages
A strategic global patent portfolio operates on the three layers aligned with product launch plans, and distribution strategy, and manufacturing footprint.
Core Inventions Layer: Protects the essential technological innovations, independent claim and defined broadest scope, dependent claims provide the fallback positions during prosecution. Improvement Layer: Encompasses the incremental innovations and design-around alternatives, a creating a "patent thicket" around the core invention.
Jurisdictional Layers: Selection must be commercially driven, market revenue determines the budget allocation, prioritising markets where products are solds, manufacturing occurs, competitors operate and enforcement is feasible.
B. Jurisdiction Selection; Balancing Cost and Strategic Value
Not every invention needs protection everywhere. Focus on markets with sales, manufacturing in, competition and enforceability. Common framework prioritises the US, EU, China, Japan and Key emerging markets.
For Indian innovators; filing first in India under section 7 establishes domestic priority but may delay the international filings, FFL allows the filing abroad without the domestic applications. Tract inventor’s residency, even one the Indian inventor triggers the section 39 Compliance.
Cost-benefit analysis: US and Europe are most expensive: India and China are cost effective. Enforcement costs matter, patents are of value if enforceable.
C. Freedom to Operate (FTO) Analysis
FTO analysis assesses whether the proposed product infringes the existing patent rights in target jurisdictions or not. Identifies the infringement risks and enables informed decisions on design around tactics, licensing.
Targeted FTO search in each jurisdiction is essential. Early FTO allows product teams to modify designs before significant R&D investment. Update FTO as product development progresses.
D. Timing Filings to Aligns with Product Launch Plans
Paris convention:[4] 12-months priority period, PCT: national phase entry up to 31 months. Provisional applications under sections 9(1): early priority dates with 12 months to file complete specifications.
Optimal Timeline:
Phase 1 (24-36 months pre-launch): Prior art search, FTO analysis, identify core inventions and improvements, map distribution strategy.
Phase 2 (18-24 months pre-launch): File provisional applications under Section 9(1), apply for FFL on Form 25, begin drafting complete specification.
Phase 3 (12-18 months pre-launch): File complete specification under Section 10(4), file PCT within 12 Months[5], prepare claim amendments, conduct comprehensive FTO
Phase 3 (12-18 months pre-launch): File complete specification under Section 10(4), file PCT within 12 months, prepare claim amendments, conduct comprehensive FTO.
Phase 4 (6-12 months pre-launchs): Enter the national phase, file on US, Europe, China. Japan, ASEAN, request expedited examination.
Phase 5 (0-12 months post-launch): Enforce rights, file continuation applications, manage a renewal fees, consider licensing.
E. Claim Drafting and Continuation Strategy
Independent claims provided over the broad protections, while dependent claims serve as a fallback position during the prosecution. In the United States, continuation, continuation-in-part (CIP), and divisional applications enables applicants to expand it or refine its patent protection while maintaining over priority, ensuring portfolios remain aligned with evolving commercial needs.
F. Portfolio Lifecycle Management
Patent portfolio management includes renewing the patents, reviewing their commercial valued, and earning through licensing, assignment, sale, or use as collateral. This ensures that businesses invest in patents that provide long-term value.
Relevant Case Laws
Novartis AG V. Union of India & Ors., (2013) 6 SCC 1 (India):[6] The Supreme Court clarified that “enhanced efficacy” under Section 3(d) must equate to “enhanced therapeutic efficacy”. The Court rejected Novartis patent for beta crystalline imatinib mesylate. This enshrined the need for careful claim drafting to meet India’s standards.
Bishwanath prasad Radhey Shyam v. Hindustan Metal Industries, (1979) 2 SCC 511 (India);[7] The Supreme Court established that patentable invention must involve an inventive step beyond just mere workshop improvement.
F. Hoddmann-La Roche Ltd. V. Cipla Ltd, 2015 (65) PTC 1 (Delhi) (India)[8]: Delhi High court addressed pharmaceutical patent enforcement and the balance between the patent rights and public health concerns.
Thaler v. Vidal, 43 F.4th 1207 (Fed. Cir. 2022) (USA):[9] The Federal Circuit held that an AI system cannot be listed as an investor, reinforcing that patent statutes presuppose human inventors.
Practical Implications
For Founder and Product Teams
Founders should conduct prior art searches and freedom to operate (FTO) analyses before investing heavily in R & D. Filing provisional applications under Section 9(1) and obtaining a Foreign Filing License (FFL) at an early stage could help to secure the priority and facilitate international filings. Jurisdiction selection should be aligned over with it on commercial objectives, prioritizing key markets. Businesses should also adopt continuation strategies where appropriate and regularly review their patent portfolio to retain valuable patents.
For Legal Practitioners
Legal practitioners should adopt the layered filing strategies covering the core inventions, improvements and design around the innovations while ensuring compliance with the Section 39 by monitoring its investor residency. Advise clients on the distinctions between patent rights and the freedom to operate and must remain updated on the jurisdiction specific developments, including the USPTO guidelines, CNIP rules and the Unitary Patent system.
For Businesses Expanding into Asia
Businesses planning to enter the Asian markets should consider strong patent ecosystems in Japan, South Korea, and Singapore. They should also account for China's evolving patent framework and India’s increasing patent filings, where expedited examination may offer a strategic advantage.
Roadmap for Founders and Product Teams
Building a global patent portfolio requires a structured 3–5 years of timeline aligned with the product development. Founders should start by conducting the prior art searches and freedom to Operate analysis, during the idea stage. Provisional applications under Section 9(1) secure priority dates, followed by the FFL application under Section 39(3) before any foreign filing. Complete specification under Section 10(4) is filed within 12 months, and PCT application preserves priority for 31 months. National Phase entry occurs in commercially strategic jurisdictions including the US, Europe, China, Japan, and ASEAN.[10] Post launch, portfolio management includes enforcement, continuation applications, renewal fee maintenance and licensing strategies. Throughout, founders must select jurisdictions based on the commercial strategy, conduct FTO before market entry, and regularly prune non-strategic patents to maximize ROI.
Conclusion
Building a global patent portfolio[11] for a product launch across multiple markets is complex but essential. Strategic alignment of filings with the product launch plans, distribution, and manufacturing requires the careful consideration of the portfolio layers and disciplined timing. India’s patent Act, 1970 provides a robust domestic framework. Section 39 enables international protection through foreign Filings Licenses. The PCT system allows streamlined multi-jurisdictional filings with it on deferred costs. However, jurisdiction-specific variations demand a clear and précised strategy. Critical components, and on the Freedom to Operate analysis, claim drafting with fallback positions, continuation strategies and the portfolio lifecycle management are essential for building on the commercially valuable portfolio. Avoiding the over-filing in low value markets and under protecting in strategic ones enables enterprises to protect innovations, enhance its competitive position and unlock licensing opportunities.
The roadmap is clear, conduct the early to prior art searches and FTO analyses, file provisional applications, obtain the foreign licenses early, select on the jurisdiction bases the commercial strategy and monitor jurisdiction specific developments continuously. Enterprises that master this discipline will thrive in the global innovation economy.
[1] Patents Act, 1970 (India), ss. 2(1)(j), 3(d), 7, 9(1), 10(4), 11B, 39, 107A, 135.
[2] Patents Rules, 2003 (India), r. 24C.
[3] Agreement on the Trade-Related Aspects of Intellectual Property Rights, 1994, art. 27-34.
[4] Paris Convention for the Protection of the Industrial Property, 1883, art. 4.
[5] Patent Cooperation Treaty, 1970, art. 1-22.
[6] Novartis AG v. Union of India & Ors., (2013) 6 SCC 1 (India).
[7] Bishwanath Prasad Radhey Shyam v. Hindustan Metal Industries, (1979) 2 SCC 511 (India).
[8] F. Hoffmann-La Roche Ltd. v. Cipla Ltd., 2015 (65) PTC 1 (Delhi) (India).
[9] Thaler v. Vidal, 43 F.4th 1207 (Fed. Cir. 2022) (United States).
[10] ASEAN Patent Examination Cooperation (ASPEC) Programme Guidelines (2025).
[11] Building a Valuable Patent Portfolio, Berkeley Center for Law & Technology (May 2026).”